Gt Biopharma Stock Price History

GTBP Stock  USD 2.40  0.16  6.25%   
Below is the normalized historical share price chart for GT Biopharma extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GT Biopharma stands at 2.40, as last reported on the 18th of March 2025, with the highest price reaching 2.55 and the lowest price hitting 2.40 during the day.
IPO Date
22nd of September 2017
200 Day MA
3.1278
50 Day MA
2.6253
Beta
0.57
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in GTBP Stock, it is important to understand the factors that can impact its price. GT Biopharma appears to be very risky, given 3 months investment horizon. GT Biopharma retains Efficiency (Sharpe Ratio) of 0.0665, which attests that the entity had a 0.0665 % return per unit of price deviation over the last 3 months. By inspecting GT Biopharma's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please utilize GT Biopharma's Semi Deviation of 6.11, standard deviation of 9.75, and Market Risk Adjusted Performance of 0.2721 to validate if our risk estimates are consistent with your expectations.
  
At this time, GT Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/18/2025, Stock Based Compensation To Revenue is likely to grow to 131.64, though Total Stockholder Equity is likely to grow to (1.6 M). . As of 03/18/2025, Price To Sales Ratio is likely to drop to 2,293. In addition to that, Price Earnings Ratio is likely to grow to -0.42. GTBP Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0665

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGTBP
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 9.78
  actual daily
87
87% of assets are less volatile

Expected Return

 0.65
  actual daily
12
88% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average GT Biopharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GT Biopharma by adding it to a well-diversified portfolio.
Price Book
2.5371
Book Value
5.414
Enterprise Value
-3.3 M
Enterprise Value Ebitda
(0.09)
Shares Float
1.7 M

GT Biopharma Stock Price History Chart

There are several ways to analyze GTBP Stock price data. The simplest method is using a basic GTBP candlestick price chart, which shows GT Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 24, 20243.2
Lowest PriceDecember 20, 20241.75

GT Biopharma March 18, 2025 Stock Price Synopsis

Various analyses of GT Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell GTBP Stock. It can be used to describe the percentage change in the price of GT Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of GTBP Stock.
GT Biopharma Price Rate Of Daily Change 0.94 
GT Biopharma Price Daily Balance Of Power(1.07)
GT Biopharma Accumulation Distribution 5,397 
GT Biopharma Price Action Indicator(0.16)

GT Biopharma March 18, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in GTBP Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use GT Biopharma intraday prices and daily technical indicators to check the level of noise trading in GTBP Stock and then apply it to test your longer-term investment strategies against GTBP.

GTBP Stock Price History Data

The price series of GT Biopharma for the period between Wed, Dec 18, 2024 and Tue, Mar 18, 2025 has a statistical range of 1.45 with a coefficient of variation of 13.46. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.43. The median price for the last 90 days is 2.38. The company completed 1:30 stock split on 5th of February 2024. GT Biopharma completed dividends distribution on 2017-08-21.
OpenHighLowCloseVolume
03/17/2025 2.55  2.55  2.40  2.40  91,750 
03/14/2025 2.48  2.56  2.32  2.56  20,465 
03/13/2025 2.44  2.65  2.42  2.48  61,019 
03/12/2025 2.47  2.53  2.34  2.49  47,231 
03/11/2025 2.47  2.54  2.32  2.48  41,254 
03/10/2025 2.44  2.57  2.38  2.49  31,480 
03/07/2025 2.32  2.56  2.30  2.44  53,546 
03/06/2025 2.33  2.53  2.28  2.37  59,611 
03/05/2025 2.25  2.43  2.21  2.43  80,177 
03/04/2025 2.34  2.42  2.11  2.18  44,404 
03/03/2025 2.40  2.43  2.23  2.33  55,375 
02/28/2025 2.30  2.47  2.14  2.38  59,043 
02/27/2025 2.15  2.40  2.09  2.30  92,425 
02/26/2025 2.04  2.38  2.03  2.36  355,174 
02/25/2025 2.46  3.12  2.02  2.46  26,668,992 
02/24/2025 2.19  2.19  2.03  2.03  14,612 
02/21/2025 2.13  2.23  2.08  2.15  17,151 
02/20/2025 2.11  2.25  2.07  2.13  7,797 
02/19/2025 2.08  2.25  2.08  2.11  15,452 
02/18/2025 2.08  2.27  2.08  2.10  15,611 
02/14/2025 2.29  2.29  2.08  2.14  21,840 
02/13/2025 2.13  2.24  2.13  2.24  27,482 
02/12/2025 2.15  2.26  2.12  2.13  7,598 
02/11/2025 2.20  2.38  2.10  2.11  40,647 
02/10/2025 2.15  2.21  2.03  2.21  9,624 
02/07/2025 2.24  2.38  2.15  2.15  17,164 
02/06/2025 2.16  2.36  2.16  2.19  18,773 
02/05/2025 2.39  2.39  2.20  2.27  25,976 
02/04/2025 2.10  2.31  2.10  2.20  25,487 
02/03/2025 2.16  2.27  2.11  2.25  36,459 
01/31/2025 2.06  2.23  2.01  2.23  20,880 
01/30/2025 2.08  2.19  2.02  2.06  30,429 
01/29/2025 2.07  2.27  2.01  2.11  45,683 
01/28/2025 2.11  2.26  2.07  2.10  59,287 
01/27/2025 2.35  2.48  2.04  2.04  92,275 
01/24/2025 2.28  2.43  2.26  2.42  30,230 
01/23/2025 2.44  2.44  2.26  2.38  22,787 
01/22/2025 2.34  2.43  2.20  2.37  29,596 
01/21/2025 2.38  2.44  2.30  2.31  25,599 
01/17/2025 2.51  2.51  2.32  2.39  72,519 
01/16/2025 2.38  2.50  2.32  2.33  87,082 
01/15/2025 2.46  2.63  2.35  2.35  94,912 
01/14/2025 2.24  2.62  2.24  2.52  114,906 
01/13/2025 2.20  2.58  1.99  2.39  3,876,205 
01/10/2025 2.55  2.66  2.51  2.65  35,420 
01/08/2025 2.75  2.75  2.55  2.55  25,154 
01/07/2025 3.05  3.05  2.84  2.87  102,333 
01/06/2025 3.08  3.10  2.95  2.99  86,415 
01/03/2025 2.99  3.10  2.92  3.00  28,308 
01/02/2025 2.99  3.05  2.80  2.94  26,998 
12/31/2024 3.16  3.16  3.05  3.05  51,423 
12/30/2024 2.93  3.20  2.61  3.05  77,930 
12/27/2024 3.04  3.14  2.80  3.02  90,889 
12/26/2024 2.86  3.20  2.82  3.09  291,756 
12/24/2024 3.03  3.39  2.72  3.20  651,001 
12/23/2024 3.24  4.10  2.42  2.81  20,856,580 
12/20/2024 1.96  2.09  1.72  1.75  86,834 
12/19/2024 2.19  2.19  1.86  1.92  32,615 
12/18/2024 2.50  2.55  2.05  2.05  82,296 
12/17/2024 2.51  2.71  2.47  2.49  29,187 
12/16/2024 2.93  2.94  2.50  2.51  18,973 

About GT Biopharma Stock history

GT Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GTBP is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GT Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GT Biopharma stock prices may prove useful in developing a viable investing in GT Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.9 M1.5 M
Net Loss-52.2 M-54.8 M

GT Biopharma Stock Technical Analysis

GT Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GT Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GT Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

GT Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GT Biopharma's price direction in advance. Along with the technical and fundamental analysis of GTBP Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GTBP to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for GTBP Stock Analysis

When running GT Biopharma's price analysis, check to measure GT Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GT Biopharma is operating at the current time. Most of GT Biopharma's value examination focuses on studying past and present price action to predict the probability of GT Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GT Biopharma's price. Additionally, you may evaluate how the addition of GT Biopharma to your portfolios can decrease your overall portfolio volatility.